CN116925119A - 一种4-10硼酸-l-苯丙氨酸中间体的制备方法 - Google Patents
一种4-10硼酸-l-苯丙氨酸中间体的制备方法 Download PDFInfo
- Publication number
- CN116925119A CN116925119A CN202210321235.5A CN202210321235A CN116925119A CN 116925119 A CN116925119 A CN 116925119A CN 202210321235 A CN202210321235 A CN 202210321235A CN 116925119 A CN116925119 A CN 116925119A
- Authority
- CN
- China
- Prior art keywords
- reagent
- formula
- alkyl
- compound
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 229960005190 phenylalanine Drugs 0.000 title abstract description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 23
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000005885 boration reaction Methods 0.000 claims abstract description 12
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000001301 oxygen Substances 0.000 claims abstract description 9
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 125000006239 protecting group Chemical group 0.000 claims abstract description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 3
- 229910052736 halogen Inorganic materials 0.000 claims abstract 2
- 125000005843 halogen group Chemical group 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 35
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 25
- 125000003118 aryl group Chemical group 0.000 claims description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 14
- 239000003960 organic solvent Substances 0.000 claims description 13
- -1 alkyl magnesium chloride Chemical compound 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 150000004791 alkyl magnesium halides Chemical group 0.000 claims description 7
- 229910052749 magnesium Inorganic materials 0.000 claims description 7
- 239000011777 magnesium Substances 0.000 claims description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 125000005842 heteroatom Chemical group 0.000 claims description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical group [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 5
- 239000007818 Grignard reagent Substances 0.000 claims description 5
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 5
- 150000004795 grignard reagents Chemical class 0.000 claims description 5
- 239000003208 petroleum Substances 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 229910001623 magnesium bromide Inorganic materials 0.000 claims description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 4
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 claims description 4
- 238000007363 ring formation reaction Methods 0.000 claims description 4
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 238000010791 quenching Methods 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 2
- NWFDYJDCSIHFAB-UHFFFAOYSA-M [Cl-].CCC(C)(C)[Mg+] Chemical compound [Cl-].CCC(C)(C)[Mg+] NWFDYJDCSIHFAB-UHFFFAOYSA-M 0.000 claims description 2
- WMJMABVHDMRMJA-UHFFFAOYSA-M [Cl-].[Mg+]C1CCCCC1 Chemical compound [Cl-].[Mg+]C1CCCCC1 WMJMABVHDMRMJA-UHFFFAOYSA-M 0.000 claims description 2
- 150000004792 aryl magnesium halides Chemical class 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 claims description 2
- CQRPUKWAZPZXTO-UHFFFAOYSA-M magnesium;2-methylpropane;chloride Chemical compound [Mg+2].[Cl-].C[C-](C)C CQRPUKWAZPZXTO-UHFFFAOYSA-M 0.000 claims description 2
- IWCVDCOJSPWGRW-UHFFFAOYSA-M magnesium;benzene;chloride Chemical compound [Mg+2].[Cl-].C1=CC=[C-]C=C1 IWCVDCOJSPWGRW-UHFFFAOYSA-M 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 2
- 125000002971 oxazolyl group Chemical group 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000001425 triazolyl group Chemical group 0.000 claims description 2
- 238000005271 boronizing Methods 0.000 claims 1
- 229910052796 boron Inorganic materials 0.000 abstract description 16
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 10
- 238000002560 therapeutic procedure Methods 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 238000009776 industrial production Methods 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 239000012847 fine chemical Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- LGQXXHMEBUOXRP-UHFFFAOYSA-N tributyl borate Chemical compound CCCCOB(OCCCC)OCCCC LGQXXHMEBUOXRP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KRSARJHWGAMIOO-VIFPVBQESA-N B(O)(O)N[C@@H](CC1=CC=CC=C1)CO Chemical compound B(O)(O)N[C@@H](CC1=CC=CC=C1)CO KRSARJHWGAMIOO-VIFPVBQESA-N 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- PZNQZSRPDOEBMS-QMMMGPOBSA-N 4-iodo-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(I)C=C1 PZNQZSRPDOEBMS-QMMMGPOBSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-BJUDXGSMSA-N Boron-10 Chemical compound [10B] ZOXJGFHDIHLPTG-BJUDXGSMSA-N 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- IHPVVBDNLUZOLT-LBPRGKRZSA-N tert-butyl n-[(2s)-1-hydroxy-3-(4-iodophenyl)propan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@H](CO)CC1=CC=C(I)C=C1 IHPVVBDNLUZOLT-LBPRGKRZSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
Abstract
Description
RT[min] | Area | Area% | Height | Type | Width[min] |
2.957 | 10.475 | 0.06 | 2.33 | BV | 0.12 |
3.052 | 22.191 | 0.13 | 3.31 | VB | 0.21 |
11.896 | 32.813 | 0.19 | 1.88 | BB | 1.12 |
17.137 | 5.328 | 0.03 | 0.53 | BB | 0.34 |
20.873 | 14.278 | 0.08 | 1.43 | BB | 0.42 |
24.109 | 121.349 | 0.70 | 12.02 | BB | 0.63 |
24.920 | 13410.552 | 77.64 | 965.92 | BV | 1.32 |
25.938 | 177.963 | 1.03 | 7.96 | VB | 0.83 |
27.944 | 7.020 | 0.04 | 0.63 | BB | 0.43 |
28.578 | 52.904 | 0.31 | 3.90 | BB | 0.69 |
30.364 | 2418.746 | 14.00 | 203.47 | BB | 0.79 |
30.779 | 24.080 | 0.14 | 2.75 | BB | 0.31 |
32.103 | 162.340 | 0.94 | 12.85 | BB | 0.72 |
33.375 | 10.971 | 0.06 | 0.78 | BB | 0.48 |
34.296 | 35.377 | 0.20 | 2.78 | BB | 0.45 |
36.040 | 202.545 | 1.17 | 14.61 | BV | 0.95 |
36.490 | 498.636 | 2.89 | 41.61 | VB | 0.55 |
46.448 | 64.840 | 0.38 | 2.92 | BBA | 1.39 |
Sum | 17272.41 |
RT[min] | Area | Area% | Height | Type | Width[min] |
4.899 | 4.409 | 0.04 | 0.37 | BB | 0.55 |
24.103 | 3.359 | 0.03 | 0.34 | BB | 0.43 |
24.897 | 11158.190 | 99.86 | 798.02 | BB | 1.93 |
30.359 | 8.218 | 0.07 | 0.76 | BB | 0.48 |
Sum | 11174.17 |
实施例 | 体系反应温度(℃) | 收率(%) | 纯度(%) |
18 | -30 | 93.2 | 99.86 |
19 | -10 | 94.5 | 99.84 |
20 | 5 | 93.4 | 99.81 |
21 | 10 | 91.7 | 99.23 |
22 | 20 | 89.8 | 99.10 |
23 | 30 | 87.9 | 98.87 |
RT[min] | Area | Area% | Height | Type | Width[min] |
4.469 | 4.062 | 0.0231 | 0.62 | BB | 0.40 |
5.124 | 17548.473 | 99.9424 | 2145.29 | BBA | 1.96 |
9.488 | 4.852 | 0.0276 | 0.31 | BV | 0.72 |
14.887 | 1.204 | 0.0069 | 0.15 | BB | 0.22 |
Sum | 17558.59 |
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210321235.5A CN116925119A (zh) | 2022-03-30 | 2022-03-30 | 一种4-10硼酸-l-苯丙氨酸中间体的制备方法 |
PCT/CN2022/100177 WO2023184731A1 (zh) | 2022-03-30 | 2022-06-21 | 一种4- 10硼酸-l-苯丙氨酸中间体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210321235.5A CN116925119A (zh) | 2022-03-30 | 2022-03-30 | 一种4-10硼酸-l-苯丙氨酸中间体的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116925119A true CN116925119A (zh) | 2023-10-24 |
Family
ID=88198845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210321235.5A Pending CN116925119A (zh) | 2022-03-30 | 2022-03-30 | 一种4-10硼酸-l-苯丙氨酸中间体的制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN116925119A (zh) |
WO (1) | WO2023184731A1 (zh) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104961756A (zh) * | 2015-06-16 | 2015-10-07 | 上海应用技术学院 | 一种(S)-Boc-4-二羟基硼酰苯丙氨酸的制备方法 |
WO2017028751A1 (zh) * | 2015-08-14 | 2017-02-23 | 南京中硼联康医疗科技有限公司 | L-bpa的制备方法 |
KR102635698B1 (ko) * | 2018-02-20 | 2024-02-14 | 오츠카 세이야쿠 가부시키가이샤 | 4-보로노페닐알라닌 제조 방법 |
CN110498810B (zh) * | 2018-05-17 | 2022-11-18 | 东莞东阳光医疗智能器件研发有限公司 | 一种l-bpa的制备方法 |
CN112174989B (zh) * | 2019-07-02 | 2023-06-20 | 江西同和药业股份有限公司 | 一种克立硼罗的制备方法 |
CN112592364A (zh) * | 2020-12-22 | 2021-04-02 | 江西同和药业股份有限公司 | 一种克立硼罗中间、制备方法体及其在制备克立硼罗中的应用 |
CN113336781A (zh) * | 2021-06-15 | 2021-09-03 | 江西同和药业股份有限公司 | 一种克立硼罗的制备方法 |
-
2022
- 2022-03-30 CN CN202210321235.5A patent/CN116925119A/zh active Pending
- 2022-06-21 WO PCT/CN2022/100177 patent/WO2023184731A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023184731A1 (zh) | 2023-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6831834B2 (ja) | L−bpaの調製方法 | |
CN112110899B (zh) | 一种吡咯替尼的合成方法 | |
Davis et al. | Structure and chemistry of a metal cluster with a four-coordinate carbide carbon atom | |
CN111072698B (zh) | 一种羟基苯硼酸的制备方法 | |
CN111760593A (zh) | 脱质子苯基桥连β-酮亚胺锂化合物在硼氢化反应中的应用 | |
CN106188116A (zh) | 一种合成吡唑‑4‑硼酸频那醇酯的方法 | |
EP4186915A1 (en) | Method for synthesizing c-nucleoside compound | |
EP3755681B1 (en) | Method of 4-boronophenylalanine production | |
CN116925119A (zh) | 一种4-10硼酸-l-苯丙氨酸中间体的制备方法 | |
CN110642878A (zh) | 氟标bpa的制备方法 | |
CN116410224A (zh) | 一种环戊二烯三氯化钛的合成工艺 | |
Peckermann et al. | Structural diversity of indium complexes containing a tetradentate (OSSO)-type bis (phenolate) ligand | |
CN116925112A (zh) | 一种硼中子俘获疗法关键中间体的制备方法 | |
CN112961176B (zh) | 一种双氧硼环中性自由基化合物的制备方法 | |
CN110498810B (zh) | 一种l-bpa的制备方法 | |
CN110862421B (zh) | 含氮杂环二茂铁衍生物的合成方法 | |
CN112876503A (zh) | 用于癌症硼中子俘获治疗药物的硼酸盐化合物及其制备 | |
CN113563198A (zh) | 四(二甲氨基)锆的合成方法 | |
CN112480172A (zh) | 硼烷-吡啶络合物在制备药物化合物中的用途 | |
CN110642879A (zh) | 氟标bpa的制备方法 | |
CN115838378B (zh) | 吡啶硼酸类化合物的连续流合成工艺 | |
CN115260103B (zh) | 一种4,5-二卤代-1-(二氟甲基)-1h-咪唑的制备方法 | |
CN115677659B (zh) | 一种阿雷替尼的制备方法 | |
CN113354675B (zh) | 一种4-羟甲基苯硼酸的制备方法 | |
Liu et al. | Synthesis and crystal structure of mono-chelating (chiral) ether side chain cyclopentadienyl lanthanide complexes with a symmetric tetradentate ligand |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240201 Address after: 246004 No. 58, xiahong Road, high tech Industrial Development Zone, Anqing City, Anhui Province Applicant after: Anhui Puli Pharmaceutical Co.,Ltd. Country or region after: China Address before: 571127 Guilin Ocean Economic Development Zone, Meilan District, Haikou City, Hainan Province Applicant before: HAINAN POLY PHARM. Co.,Ltd. Country or region before: China Applicant before: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. Applicant before: Anhui Puli Pharmaceutical Co.,Ltd. |